BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31244223)

  • 21. Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection.
    Mohamed MF; Seleem MN
    Drug Des Devel Ther; 2014; 8():1979-83. PubMed ID: 25378910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection.
    Mohammad H; Kyei-Baffour K; Abutaleb NS; Dai M; Seleem MN
    J Glob Antimicrob Resist; 2019 Dec; 19():1-7. PubMed ID: 31051286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice.
    Chhibber T; Gondil VS; Sinha VR
    AAPS PharmSciTech; 2020 Jan; 21(2):43. PubMed ID: 31897806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E
    Ikeh MAC; Fidel PL; Noverr MC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.
    Meddles-Torres C; Hu S; Jurgens C
    J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methicillin-resistant Staphylococcus aureus colonization of infectious and non-infectious skin and soft tissue lesions in patients in Tehran.
    Khalili H; Najar-Peerayeh S; Mahrooghi M; Mansouri P; Bakhshi B
    BMC Microbiol; 2021 Oct; 21(1):282. PubMed ID: 34657594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biological synthesis of gold/perlite nanocomposite using Urtica dioica extract and its chitosan-capped derivative for healing wounds infected with methicillin-resistant Staphylococcus aureus.
    Choodari Gharehpapagh A; Farahpour MR; Jafarirad S
    Int J Biol Macromol; 2021 Jul; 183():447-456. PubMed ID: 33932414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice.
    Heunis TD; Smith C; Dicks LM
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3928-35. PubMed ID: 23733456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model.
    Ovchinnikov KV; Kranjec C; Telke A; Kjos M; Thorstensen T; Scherer S; Carlsen H; Diep DB
    Front Immunol; 2021; 12():676534. PubMed ID: 34276663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains.
    Giordani B; Costantini PE; Fedi S; Cappelletti M; Abruzzo A; Parolin C; Foschi C; Frisco G; Calonghi N; Cerchiara T; Bigucci F; Luppi B; Vitali B
    Eur J Pharm Biopharm; 2019 Jun; 139():246-252. PubMed ID: 30991089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The atopic dermatitis-like lesion and the associated MRSA infection and barrier dysfunction can be alleviated by 2,4-dimethoxy-6-methylbenzene-1,3-diol from Antrodia camphorata.
    Yang SC; Huang TH; Chiu CH; Chou WL; Alalaiwe A; Yeh YC; Su KW; Fang JY
    J Dermatol Sci; 2018 Nov; 92(2):188-196. PubMed ID: 30219520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice.
    Mohammad H; Abutaleb NS; Dieterly AM; Lyle LT; Seleem MN
    PLoS One; 2021; 16(2):e0247508. PubMed ID: 33617589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.
    Chhibber S; Kaur T; Sandeep Kaur
    PLoS One; 2013; 8(2):e56022. PubMed ID: 23418497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platensimycin and platencin congeners from Streptomyces platensis.
    Zhang C; Ondeyka J; Herath K; Jayasuriya H; Guan Z; Zink DL; Dietrich L; Burgess B; Ha SN; Wang J; Singh SB
    J Nat Prod; 2011 Mar; 74(3):329-40. PubMed ID: 21214253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of neutrophil function by interleukin-18 therapy protects burn-injured mice from methicillin-resistant Staphylococcus aureus.
    Kinoshita M; Miyazaki H; Ono S; Inatsu A; Nakashima H; Tsujimoto H; Shinomiya N; Saitoh D; Seki S
    Infect Immun; 2011 Jul; 79(7):2670-80. PubMed ID: 21536791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEI/NONOates-doped PLGA nanoparticles for eradicating methicillin-resistant Staphylococcus aureus biofilm in diabetic wounds via binding to the biofilm matrix.
    Hasan N; Cao J; Lee J; Naeem M; Hlaing SP; Kim J; Jung Y; Lee BL; Yoo JW
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109741. PubMed ID: 31349480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bactericidal efficacy of mupirocin in multi-antibiotic resistant Staphylococcus aureus burn wound infection.
    Rode H; de Wet PM; Millar AJ; Cywes S
    J Antimicrob Chemother; 1988 May; 21(5):589-95. PubMed ID: 3134320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection.
    Thangamani S; Nepal M; Chmielewski J; Seleem MN
    Drug Des Devel Ther; 2015; 9():5749-54. PubMed ID: 26543355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
    Hilliard JJ; Fernandez J; Melton J; Macielag MJ; Goldschmidt R; Bush K; Abbanat D
    Antimicrob Agents Chemother; 2009 May; 53(5):2028-33. PubMed ID: 19273686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platensimycin is a selective FabF inhibitor with potent antibiotic properties.
    Wang J; Soisson SM; Young K; Shoop W; Kodali S; Galgoci A; Painter R; Parthasarathy G; Tang YS; Cummings R; Ha S; Dorso K; Motyl M; Jayasuriya H; Ondeyka J; Herath K; Zhang C; Hernandez L; Allocco J; Basilio A; Tormo JR; Genilloud O; Vicente F; Pelaez F; Colwell L; Lee SH; Michael B; Felcetto T; Gill C; Silver LL; Hermes JD; Bartizal K; Barrett J; Schmatz D; Becker JW; Cully D; Singh SB
    Nature; 2006 May; 441(7091):358-61. PubMed ID: 16710421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.